DE3854300D1 - Lymphocyteninhibierung durch hla-peptide. - Google Patents

Lymphocyteninhibierung durch hla-peptide.

Info

Publication number
DE3854300D1
DE3854300D1 DE3854300T DE3854300T DE3854300D1 DE 3854300 D1 DE3854300 D1 DE 3854300D1 DE 3854300 T DE3854300 T DE 3854300T DE 3854300 T DE3854300 T DE 3854300T DE 3854300 D1 DE3854300 D1 DE 3854300D1
Authority
DE
Germany
Prior art keywords
ctl
peptides
hla peptides
alpha
lymphocyte inhibition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3854300T
Other languages
English (en)
Other versions
DE3854300T2 (de
Inventor
Alan Krensky
Peter Parham
Carol Clayberger
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leland Stanford Junior University
Original Assignee
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leland Stanford Junior University filed Critical Leland Stanford Junior University
Publication of DE3854300D1 publication Critical patent/DE3854300D1/de
Application granted granted Critical
Publication of DE3854300T2 publication Critical patent/DE3854300T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70539—MHC-molecules, e.g. HLA-molecules
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • G01N33/56977—HLA or MHC typing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Urology & Nephrology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biotechnology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE3854300T 1987-01-30 1988-01-27 Lymphocyteninhibierung durch hla-peptide. Expired - Fee Related DE3854300T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US884687A 1987-01-30 1987-01-30
US13854787A 1987-12-24 1987-12-24
PCT/US1988/000245 WO1988005784A1 (en) 1987-01-30 1988-01-27 Lymphocyte inhibition by hla peptides

Publications (2)

Publication Number Publication Date
DE3854300D1 true DE3854300D1 (de) 1995-09-14
DE3854300T2 DE3854300T2 (de) 1996-01-11

Family

ID=26678694

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3854300T Expired - Fee Related DE3854300T2 (de) 1987-01-30 1988-01-27 Lymphocyteninhibierung durch hla-peptide.

Country Status (7)

Country Link
EP (1) EP0365525B1 (de)
AT (1) ATE126237T1 (de)
AU (1) AU619458B2 (de)
CA (1) CA1339185C (de)
DE (1) DE3854300T2 (de)
DK (1) DK549188A (de)
WO (1) WO1988005784A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7011834B1 (en) 1987-01-30 2006-03-14 The Board Of Trustees Of Leland Stanford Junior University Immunomodulating dimers
US5888512A (en) * 1987-01-30 1999-03-30 Board Of Trustees Of The Leland Stanford Junior University Lymphocyte activity regulation by HLA peptides
US5723128A (en) * 1987-01-30 1998-03-03 The Board Of Trustees Of The Leland Stanford Junior University Cytotoxic T-cell lymphocyte ("CTL") activity regulation by class I MHC peptides
EP0459978B1 (de) * 1989-03-03 1997-07-16 The Regents Of The University Of California Klasse i-mhc-modulation von oberflächenrezeptoraktivität
DE4143467C2 (de) * 1991-05-17 1995-02-09 Max Planck Gesellschaft Peptidmotiv und dessen Verwendung
AU673985B2 (en) * 1991-11-08 1996-12-05 Board Of Trustees Of The Leland Stanford Junior University CD8 binding domain peptides
ZA932568B (en) * 1992-04-24 1993-11-12 Baylor College Midecine A Non Production of recombinant human lactoferrin
CA2142007C (en) * 1992-08-11 2007-10-30 Robert Glen Urban Immunomodulatory peptides
DE4238416A1 (de) * 1992-11-13 1994-05-19 Max Planck Gesellschaft Bestimmung von Peptidmotiven auf MHC-Molekülen
AU6034894A (en) * 1993-02-17 1994-09-14 Immune Network Research Ltd Methods for modifying the t cell repertoire of the immune system
US6162434A (en) * 1995-05-03 2000-12-19 Sangstat Medical Corporation Cytomodulating peptide for inhibiting lymphocyte activity
US5753625A (en) * 1995-05-12 1998-05-19 Sangstat Medical Corporation Treatment for inhibiting the progression of autoimmune disease
US6056952A (en) * 1995-08-30 2000-05-02 The United States Of America As Represented By The Department Of Health And Human Services Selective elimination of T cells that recognize specific preselected targets
US6436903B1 (en) 1996-05-22 2002-08-20 Stanford University (Board Of Trustees Of The Leland Standford Junior University) Immunomodulating compounds comprising d-isomers of amino acids
AU3209897A (en) * 1996-05-24 1997-12-09 Board Of Trustees Of The Leland Stanford Junior University Immunomodulating dimers
US6696545B1 (en) 1997-04-11 2004-02-24 Sangstat Medical Corporation Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
IL132310A0 (en) 1997-04-11 2001-03-19 Sangstat Medical Corp Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
EP1525216A4 (de) 2002-01-24 2009-07-08 Sangstat Medical Corp Kombinationstherapie zur behandlung von hiv-infektion
WO2006115509A2 (en) 2004-06-24 2006-11-02 Novartis Vaccines And Diagnostics Inc. Small molecule immunopotentiators and assays for their detection

Also Published As

Publication number Publication date
CA1339185C (en) 1997-07-29
ATE126237T1 (de) 1995-08-15
EP0365525B1 (de) 1995-08-09
AU1342388A (en) 1988-08-24
DK549188D0 (da) 1988-09-30
EP0365525A4 (en) 1990-12-12
EP0365525A1 (de) 1990-05-02
AU619458B2 (en) 1992-01-30
WO1988005784A1 (en) 1988-08-11
DE3854300T2 (de) 1996-01-11
DK549188A (da) 1988-11-30

Similar Documents

Publication Publication Date Title
DE3854300D1 (de) Lymphocyteninhibierung durch hla-peptide.
ES2128362T3 (es) Fragmentos de proteinas de prion.
ATE183514T1 (de) Peptide des menschlichen proteins p53 zum gebrauch in menschlichen-zytotoxischen-t-zell- antwort-induzierenden kompositionen sowie menschliche p53-protein-spezifische t-lymphocyten
GR3034964T3 (en) Lymphocyte activity regulation by hla peptides.
IL94039A0 (en) Antibodies to anti-cytotoxic proteins
DK0503648T3 (da) CD2-bindingsdomæne af lymfocytfunktion-associeret antigen 3
ZA975851B (en) Hepatocyte grown factor receptor agonists and uses thereof
DE68926675D1 (de) Von mhc gestützte konjugate zur verwendung bei der steigerung der autoimmunität
DK0643767T3 (da) Osteogene peptider
ATE250625T1 (de) IM WESENTLICHEN REINES ZONULIN ALS PHYSIOLOGISCHER MODULATOR VON ßTIGHT JUNCTIONSß BEI SÄUGERN
IL134982A0 (en) Antibodies which react with polypeptides of cd-44 surface proteins and diagnostic and pharmaceutical compositions prepared therewith
DK1129186T3 (da) Et faktor VIII-polypeptid med faktor VIII:C-aktivitet
DE69434384D1 (de) Metalkomplexbildner
AU5214893A (en) Antibodies specific to extracellular segments of human and immunoglobulin anchoring peptides
JPS6456697A (en) Viii factor bonded domain of von willebrand's factor
ES2186717T3 (es) Regulacion de la actividad de los linfocitos t citotoxicos ("ctl") mediante peptidos de la clase i del mhc.
ATE63126T1 (de) Tetra- und penta-peptide mit der sequenz lysylarginyl-aspartyl, und ihre verwendung als antithrombotika.
DE69330352D1 (de) Mittel und methoden zur verbesserung der keratinocytenadhäsion an der haut
ATE225806T1 (de) D-2-alkyltryptophan enthaltende polypeptide mit wachstumhormon freisetzender aktivitaet
DK0625157T3 (da) Blodplade-GPIIIaP1A1- og -P1A2-epitoper og fremstilling og anvendelse deraf
ATE139259T1 (de) Selbstantigen der primären lebercirrhose
DK0463053T3 (da) Fremstilling og anvendelse af anthelmintiske midler og beskyttende immunogener
ATE196767T1 (de) Neue cocain-derivate und protein- und polypeptid- cocain-derivate, konjugate und markierte verbindungen
SE8604991D0 (sv) Snake venom growth arresting peptide
GB2259706B (en) Porcine adipocyte antigens and their use in the immunological control of fat

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee